DAM
CRSP icon

Draper Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Draper Asset Management’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,892
Closed -$426K – 24
2024
Q2 		$426K Sell
7,892
-20
-0.3% -$1.16K 0.32% 17
2024
Q1 		$521K Sell
7,912
-171
-2% -$12.2K 0.45% 16
2023
Q4 		$506K Buy
8,083
+36
+0.4% +$1.99K 0.48% 14
2023
Q3 		$365K Sell
8,047
-76
-0.9% -$3.92K 0.39% 19
2023
Q2 		$456K Sell
8,123
-221
-3% -$12.5K 0.45% 17
2023
Q1 		$377K Sell
8,344
-2,522
-23% -$122K 0.48% 15
2022
Q4 		$442K Buy
10,866
+798
+8% +$42.3K 0.61% 18
2022
Q3 		$658K Buy
10,068
+801
+9% +$58K 0.8% 16
2022
Q2 		$563K Buy
9,267
+1,056
+13% +$62.1K 0.66% 17
2022
Q1 		$515K Buy
8,211
+1,202
+17% +$75.5K 0.43% 19
2021
Q4 		$531K Buy
7,009
+1,308
+23% +$114K 0.43% 17
2021
Q3 		$638K Buy
5,701
+910
+19% +$114K 0.6% 19
2021
Q2 		$776K Buy
4,791
+1,094
+30% +$133K 0.77% 17
2021
Q1 		$450K Buy
3,697
+1,937
+110% +$292K 0.48% 22
2020
Q4 		$269K Buy
+1,760
New +$208K 0.27% 31

Other funds holding CRSP

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Draper Asset Management's CRSP Position: Q3 2024 in Review

Draper Asset Management sold out of CRISPR Therapeutics (CRSP) in Q3 2024, closing a stake of 7,892 shares — an estimated $426K sold.

Draper Asset Management first reported a position in CRSP in Q4 2020 and held it in 15 quarters. The position peaked at $776K in Q2 2021. 416 funds tracked by Wall St. Rank hold CRSP as of Q3 2024.

  • Draper Asset Management reported no remaining CRISPR Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Draper Asset Management sold 7,892 CRISPR Therapeutics shares in Q3 2024, an estimated $426K.
  • Draper Asset Management first reported a position in CRISPR Therapeutics in Q4 2020 and held it in 15 quarters.
  • Draper Asset Management's CRISPR Therapeutics position peaked at $776K in Q2 2021.
  • 416 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2024.

Based on Draper Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.